FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy. (2018)
Attributed to:
Mechanisms of mature B-cell tumour pathogenesis and of the interplay between host-immunity and these tumours.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/2162402x.2017.1423183
PubMed Identifier: 29721381
Publication URI: http://europepmc.org/abstract/MED/29721381
Type: Journal Article/Review
Volume: 7
Parent Publication: Oncoimmunology
Issue: 5
ISSN: 2162-4011